These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16790946)

  • 21. Incident pain and analgesic consumption decrease after samarium infusion: a pilot study.
    Ripamonti C; Fagnoni E; Campa T; Seregni E; Maccauro M; Bombardieri E
    Support Care Cancer; 2007 Mar; 15(3):339-42. PubMed ID: 16967302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of bone pain secondary to metastases using samarium-153-EDTMP.
    Etchebehere EC; Pereira Neto CA; Lima MC; Santos Ade O; Ramos CD; Silva CM; Camargo EE
    Sao Paulo Med J; 2004 Sep; 122(5):208-12. PubMed ID: 15558143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ¹⁷⁷Lu-EDTMP for treatment of bone pain in patients with disseminated skeletal metastases.
    Shinto AS; Shibu D; Kamaleshwaran KK; Das T; Chakraborty S; Banerjee S; Thirumalaisamy P; Das P; Veersekar G
    J Nucl Med Technol; 2014 Mar; 42(1):55-61. PubMed ID: 24503346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of samarium-153-ethylenediaminetetramethylene phosphonic acid with pamidronate disodium in the treatment of patients with painful metastatic bone cancer.
    Wang RF; Zhang CL; Zhu SL; Zhu M
    Med Princ Pract; 2003; 12(2):97-101. PubMed ID: 12634464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective evaluation of bone pain palliation after samarium-153-EDTMP therapy.
    Sapienza MT; Ono CR; Guimarães MI; Watanabe T; Costa PA; Buchpiguel CA
    Rev Hosp Clin Fac Med Sao Paulo; 2004 Dec; 59(6):321-8. PubMed ID: 15654484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (177)Lu-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: a phase II study.
    Agarwal KK; Singla S; Arora G; Bal C
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):79-88. PubMed ID: 25070686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cost-effectiveness of samarium-153-EDTMP for the treatment of pain due to multiple bone metastases in hormone-refractory prostate cancer versus conventional pain therapy, in Portugal].
    Macedo A; Araújo A; Melo FC; Nunes G; Cantinho G; Amorin I
    Acta Med Port; 2006; 19(5):421-6. PubMed ID: 17376329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma.
    Anderson P; Nuñez R
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1517-27. PubMed ID: 18020921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative analysis of patients not responding to a single dose of 153Sm-EDTMP palliative treatment for painful skeletal metastases.
    Tian J; Cao L; Zhang J; Ouyang Q; Hou Q; He Y
    Chin Med J (Engl); 2002 Jun; 115(6):824-8. PubMed ID: 12123545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis.
    Serafini AN
    Q J Nucl Med; 2001 Mar; 45(1):91-9. PubMed ID: 11456381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of ¹⁸F-fluoride PET-CT on implementing early treatment of painful bone metastases with Sm-153 EDTMP.
    Storto G; Gallicchio R; Pellegrino T; Nardelli A; De Luca S; Capacchione D; Sirignano C; Pace L
    Nucl Med Biol; 2013 May; 40(4):518-23. PubMed ID: 23522973
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Askari E; Harsini S; Vahidfar N; Divband G; Sadeghi R
    Cancer Biother Radiopharm; 2021 Jun; 36(5):383-390. PubMed ID: 33259726
    [No Abstract]   [Full Text] [Related]  

  • 33. Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial.
    Serafini AN; Houston SJ; Resche I; Quick DP; Grund FM; Ell PJ; Bertrand A; Ahmann FR; Orihuela E; Reid RH; Lerski RA; Collier BD; McKillop JH; Purnell GL; Pecking AP; Thomas FD; Harrison KA
    J Clin Oncol; 1998 Apr; 16(4):1574-81. PubMed ID: 9552068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [153Sm-EDTMP for moderate and severe bone cancer pain].
    Deng H; Luo S; Tan T; Mo T; Liang Z; Pu M; Jiao J; Zhong S; Wang Q; Hu Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):391-4. PubMed ID: 8732058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain.
    Sartor O; Reid RH; Bushnell DL; Quick DP; Ell PJ
    Cancer; 2007 Feb; 109(3):637-43. PubMed ID: 17167764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Myelotoxicity after systemic radionuclide therapy of painful bone metastases with 153Samarium-EDTMP ].
    Dolezal J; Vizd'a J; Cermáková E
    Vnitr Lek; 2003 Mar; 49(3):189-93. PubMed ID: 12728593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases.
    Turner JH; Claringbold PG; Hetherington EL; Sorby P; Martindale AA
    J Clin Oncol; 1989 Dec; 7(12):1926-31. PubMed ID: 2585026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal treatment of painful bone metastases with Samarium EDTMP in a haemodialysis patient: effectiveness and safety of internal radiotherapy.
    Skalli S; Desruet MD; Bourre JC; Caravel JP; Vuillez JP
    Nephrol Dial Transplant; 2009 Aug; 24(8):2598-600. PubMed ID: 19369693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of painful bone metastases in hormone-refractory prostate cancer with zoledronic acid and samarium-153-ethylenediaminetetramethylphosphonic acid combined.
    Lam MG; de Klerk JM; Zonnenberg BA
    J Palliat Med; 2009 Jul; 12(7):649-51. PubMed ID: 19594354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Samarium-153-EDTMP: pharmacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer.
    Farhanghi M; Holmes RA; Volkert WA; Logan KW; Singh A
    J Nucl Med; 1992 Aug; 33(8):1451-8. PubMed ID: 1378887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.